Logo image of CNEY

CN ENERGY GROUP INC-A (CNEY) Stock Fundamental Analysis

USA - NASDAQ:CNEY - VGG2181K2048 - Common Stock

2.29 USD
-0.04 (-1.72%)
Last: 10/3/2025, 8:00:01 PM
2.2707 USD
-0.02 (-0.84%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CNEY. CNEY was compared to 83 industry peers in the Chemicals industry. While CNEY seems to be doing ok healthwise, there are quite some concerns on its profitability. CNEY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CNEY had negative earnings in the past year.
CNEY had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNEY reported negative net income in multiple years.
CNEY had a negative operating cash flow in each of the past 5 years.
CNEY Yearly Net Income VS EBIT VS OCF VS FCFCNEY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.27%, CNEY is doing worse than 78.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of -14.49%, CNEY is doing worse than 69.88% of the companies in the same industry.
Industry RankSector Rank
ROA -14.27%
ROE -14.49%
ROIC N/A
ROA(3y)-5.46%
ROA(5y)-1.69%
ROE(3y)-5.47%
ROE(5y)-1.15%
ROIC(3y)N/A
ROIC(5y)N/A
CNEY Yearly ROA, ROE, ROICCNEY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

CNEY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNEY Yearly Profit, Operating, Gross MarginsCNEY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

CNEY does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNEY has more shares outstanding than it did 1 year ago.
CNEY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNEY has an improved debt to assets ratio.
CNEY Yearly Shares OutstandingCNEY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
CNEY Yearly Total Debt VS Total AssetsCNEY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.51 indicates that CNEY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.51, CNEY is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
CNEY has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
CNEY has a better Debt to Equity ratio (0.01) than 95.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.51
ROIC/WACCN/A
WACC6.52%
CNEY Yearly LT Debt VS Equity VS FCFCNEY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 42.41 indicates that CNEY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 42.41, CNEY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CNEY has a Quick Ratio of 40.11. This indicates that CNEY is financially healthy and has no problem in meeting its short term obligations.
CNEY's Quick ratio of 40.11 is amongst the best of the industry. CNEY outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 42.41
Quick Ratio 40.11
CNEY Yearly Current Assets VS Current LiabilitesCNEY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. Growth

3.1 Past

The earnings per share for CNEY have decreased strongly by -10.66% in the last year.
CNEY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.99%.
Measured over the past years, CNEY shows a very strong growth in Revenue. The Revenue has been growing by 36.15% on average per year.
EPS 1Y (TTM)-10.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-222.95%
Revenue 1Y (TTM)-11.99%
Revenue growth 3Y36.93%
Revenue growth 5Y36.15%
Sales Q2Q%-44.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNEY Yearly Revenue VS EstimatesCNEY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

0

4. Valuation

4.1 Price/Earnings Ratio

CNEY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNEY Price Earnings VS Forward Price EarningsCNEY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNEY Per share dataCNEY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60 -80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CNEY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CN ENERGY GROUP INC-A

NASDAQ:CNEY (10/3/2025, 8:00:01 PM)

After market: 2.2707 -0.02 (-0.84%)

2.29

-0.04 (-1.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-28.1%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap6.92M
Analysts0
Price TargetN/A
Short Float %5.9%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)-96.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS16.87
BVpS32.09
TBVpS32.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.27%
ROE -14.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.46%
ROA(5y)-1.69%
ROE(3y)-5.47%
ROE(5y)-1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 42.41
Quick Ratio 40.11
Altman-Z 3.51
F-Score4
WACC6.52%
ROIC/WACCN/A
Cap/Depr(3y)99.76%
Cap/Depr(5y)131.56%
Cap/Sales(3y)3.64%
Cap/Sales(5y)6.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-222.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.99%
Revenue growth 3Y36.93%
Revenue growth 5Y36.15%
Sales Q2Q%-44.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-102.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y92.14%
OCF growth 3YN/A
OCF growth 5YN/A